Impax Laboratories to Present at Upcoming Investor Conferences - WMBB News 13 - The Panhandle's News Leader

Impax Laboratories to Present at Upcoming Investor Conferences

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Impax Laboratories, Inc.

HAYWARD, Calif., May 12, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will present at two upcoming investor conferences in May.

Bank of America Merrill Lynch 2014 Health Care Conference
Impax will present at the Bank of America Merrill Lynch Health Care Conference on Thursday, May 15, 2014 at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time).

UBS 2014 Global Healthcare Conference
Impax will present at the UBS Global Healthcare Conference on Tuesday, May 20, 2014 at 2:00 p.m. Eastern Time.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at www.impaxlabs.com.  This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Company Contact: 
Mark Donohue
Investor Relations and Corporate Communications 
(215) 558-4526                                                       
www.impaxlabs.com

©2012 PR Newswire. All Rights Reserved.